Both in Biotechnology
CG Oncology vs Relay Therapeutics
Over the past year CGON returned +49.5% and RLAY returned +157.0%; their daily moves had a correlation of 0.33.
CGON +49.5% RLAY +157.0%Growth of $1, one year, split-adjusted
| Metric | CGON | RLAY |
|---|---|---|
| Price | $64.68 | $18.35 |
| Market cap | $5.73B | $4.02B |
| Today | +1.91% | −5.75% |
| 1 month | −5.4% | −0.8% |
| 6 months | −2.4% | +44.3% |
| Year to date | +55.8% | +116.9% |
| 1 year | +50.5% | +151.0% |
| Revenue growth (YoY) | — | −48.3% |
| Gross margin | −239.2% | 100.0% |
| Net margin | −6832.8% | −23916.3% |
| P/E (TTM) | — | — |
| Price / sales | 920.6× | 388.5× |
| Net cash | $1.03B | $910.9M |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 47.2% |
| Short % of float | 12.9% | 27.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).